Embree Financial Group Has $315,000 Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Embree Financial Group trimmed its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 10.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,499 shares of the exchange traded fund’s stock after selling 401 shares during the period. Embree Financial Group’s holdings in SPDR S&P Biotech ETF were worth $315,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Bank of Montreal Can grew its holdings in SPDR S&P Biotech ETF by 8.3% in the 2nd quarter. Bank of Montreal Can now owns 231,432 shares of the exchange traded fund’s stock valued at $21,556,000 after buying an additional 17,749 shares during the last quarter. Toronto Dominion Bank boosted its position in shares of SPDR S&P Biotech ETF by 16.3% in the second quarter. Toronto Dominion Bank now owns 21,743 shares of the exchange traded fund’s stock valued at $2,016,000 after acquiring an additional 3,048 shares during the period. Main Management Fund Advisors LLC grew its stake in shares of SPDR S&P Biotech ETF by 8.3% in the second quarter. Main Management Fund Advisors LLC now owns 598,200 shares of the exchange traded fund’s stock worth $55,459,000 after acquiring an additional 45,700 shares during the last quarter. Northwestern Mutual Wealth Management Co. increased its position in SPDR S&P Biotech ETF by 1.6% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,145,049 shares of the exchange traded fund’s stock worth $106,158,000 after acquiring an additional 18,202 shares during the period. Finally, Granite FO LLC acquired a new position in SPDR S&P Biotech ETF during the 2nd quarter valued at $223,000.

SPDR S&P Biotech ETF Price Performance

Shares of SPDR S&P Biotech ETF stock opened at $92.46 on Friday. The firm has a fifty day moving average price of $93.34 and a two-hundred day moving average price of $96.89. SPDR S&P Biotech ETF has a fifty-two week low of $81.14 and a fifty-two week high of $105.47. The company has a market cap of $7.05 billion, a PE ratio of 11.47 and a beta of 1.11.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.